J. Goldman & Co’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-116,842
| Closed | -$1.27M | – | 456 |
|
|
2024
Q2 | $1.27M | Buy |
+116,842
| New | +$1.27M | 0.04% | 194 |
|
|
2017
Q2 | – | Sell |
-9,300
| Closed | -$661K | – | 284 |
|
|
2017
Q1 | $661K | Sell |
9,300
-11,900
| -56% | -$846K | 0.03% | 159 |
|
|
2016
Q4 | $1.08M | Sell |
21,200
-29,400
| -58% | -$1.5M | 0.07% | 130 |
|
|
2016
Q3 | $2.33M | Buy |
50,600
+4,100
| +9% | +$189K | 0.13% | 100 |
|
|
2016
Q2 | $1.4M | Sell |
46,500
-55,500
| -54% | -$1.67M | 0.07% | 125 |
|
|
2016
Q1 | $3.27M | Buy |
+102,000
| New | +$3.27M | 0.2% | 83 |
|